2,218
Views
0
CrossRef citations to date
0
Altmetric
Addendum

Vascular-targeted recombinant adeno-associated viral vectors for the treatment of rare diseases

, &
Article: e1220470 | Received 01 Jun 2016, Accepted 28 Jul 2016, Published online: 25 Aug 2016

References

  • Samulski RJ, Muzyczka N. AAV-Mediated Gene Therapy for Research and Therapeutic Purposes. Annu Rev Virol 2014; 1:427-51; PMID:26958729; http://dx.doi.org/10.1146/annurev-virology-031413-085355
  • Morrison C. $1-million price tag set for Glybera gene therapy. Nat Biotechnol 2015; 33:217-8; PMID:25748892; http://dx.doi.org/10.1038/nbt0315-217
  • Hegele RA, Ginsberg HN, Chapman MJ, Nordestgaard BG, Kuivenhoven JA, Averna M, Boren J, Bruckert E, Catapano AL, Descamps OS, et al. The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management. Lancet Diabetes Endocrinol 2014; 2:655-66; PMID:24731657; http://dx.doi.org/10.1016/S2213-8587(13)70191-8
  • Zincarelli C, Soltys S, Rengo G, Rabinowitz JE. Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection. Mol Ther 2008; 16:1073-80; PMID:18414476; http://dx.doi.org/10.1038/mt.2008.76
  • Bell P, Moscioni AD, McCarter RJ, Wu D, Gao G, Hoang A, Sanmiguel JC, Sun X, Wivel NA, Raper SE, et al. Analysis of tumors arising in male B6C3F1 mice with and without AAV vector delivery to liver. Mol Ther 2006; 14:34-44; PMID:16682254; http://dx.doi.org/10.1016/j.ymthe.2006.03.008
  • Nault JC, Datta S, Imbeaud S, Franconi A, Mallet M, Couchy G, Letouze E, Pilati C, Verret B, Blanc JF, et al. Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas. Nat Genet 2015; 47:1187-93; PMID:26301494; http://dx.doi.org/10.1038/ng.3389
  • Körbelin J, Dogbevia G, Michelfelder S, Ridder DA, Hunger A, Wenzel J, Seismann H, Lampe M, Bannach J, Pasparakis M, et al. A brain microvasculature endothelial cell-specific viral vector with the potential to treat neurovascular and neurological diseases. EMBO Mol Med 2016; 8(6):609-25; PMID:27137490; http://dx.doi.org/10.15252/emmm.201506078
  • Weksler BB, Subileau EA, Perriere N, Charneau P, Holloway K, Leveque M, Tricoire-Leignel H, Nicotra A, Bourdoulous S, Turowski P, et al. Blood-brain barrier-specific properties of a human adult brain endothelial cell line. FASEB J 2005; 19:1872-4; PMID:16141364
  • Assmann JC, Korbelin J, Schwaninger M. Genetic manipulation of brain endothelial cells in vivo. Biochim Et Biophy Acta 2016; 1862:381-94; http://dx.doi.org/10.1016/j.bbadis.2015.10.006
  • Chen YH, Chang M, Davidson BL. Molecular signatures of disease brain endothelia provide new sites for CNS-directed enzyme therapy. Nat Med 2009; 15:1215-8; PMID:19749771; http://dx.doi.org/10.1038/nm.2025
  • Meuwissen ME, Mancini GM. Neurological findings in incontinentia pigmenti; a review. Eur J Med Genet 2012; 55:323-31; PMID:22564885; http://dx.doi.org/10.1016/j.ejmg.2012.04.007
  • Ridder DA, Wenzel J, Muller K, Tollner K, Tong XK, Assmann JC, Stroobants S, Weber T, Niturad C, Fischer L, et al. Brain endothelial TAK1 and NEMO safeguard the neurovascular unit. J Exp Med 2015; 212:1529-49; PMID:26347470; http://dx.doi.org/10.1084/jem.20150165
  • Michelfelder S, Trepel M. Adeno-associated viral vectors and their redirection to cell-type specific receptors. Adv Genet 2009; 67:29-60; PMID:19914449; http://dx.doi.org/10.1016/S0065-2660(09)67002-4
  • Buchholz CJ, Friedel T, Buning H. Surface-engineered viral vectors for selective and cell type-specific gene delivery. Trend Biotechnol 2015; 33:777-90; http://dx.doi.org/10.1016/j.tibtech.2015.09.008
  • Grimm D, Lee JS, Wang L, Desai T, Akache B, Storm TA, Kay MA. In vitro and in vivo gene therapy vector evolution via multispecies interbreeding and re-targeting of adeno-associated viruses. J Virol 2008; 82:5887-911; PMID:18400866; http://dx.doi.org/10.1128/JVI.00254-08
  • Lisowski L, Dane AP, Chu K, Zhang Y, Cunningham SC, Wilson EM, Nygaard S, Grompe M, Alexander IE, Kay MA. Selection and evaluation of clinically relevant AAV variants in a xenograft liver model. Nature 2014; 506:382-6; PMID:24390344; http://dx.doi.org/10.1038/nature12875
  • Müller OJ, Kaul F, Weitzman MD, Pasqualini R, Arap W, Kleinschmidt JA, Trepel M. Random peptide libraries displayed on adeno-associated virus to select for targeted gene therapy vectors. Nat Biotechnol 2003; 21:1040-6; PMID:12897791; http://dx.doi.org/10.1038/nbt856
  • Perabo L, Buning H, Kofler DM, Ried MU, Girod A, Wendtner CM, Enssle R, Hallek M. In vitro selection of viral vectors with modified tropism: The adeno-associated virus display. Mol Ther 2003; 8:151-7; PMID:12842438; http://dx.doi.org/10.1016/S1525-0016(03)00123-0
  • Varadi K, Michelfelder S, Korff T, Hecker M, Trepel M, Katus HA, Kleinschmidt JA, Muller OJ. Novel random peptide libraries displayed on AAV serotype 9 for selection of endothelial cell-directed gene transfer vectors. Gene Ther 2012; 19:800-9; PMID:21956692; http://dx.doi.org/10.1038/gt.2011.143
  • Michelfelder S, Kohlschutter J, Skorupa A, Pfennings S, Muller O, Kleinschmidt JA, Trepel M. Successful expansion but not complete restriction of tropism of adeno-associated virus by in vivo biopanning of random virus display Peptide libraries. PLoS One 2009; 4:e5122; PMID:19357785; http://dx.doi.org/10.1371/journal.pone.0005122
  • Ying Y, Muller OJ, Goehringer C, Leuchs B, Trepel M, Katus HA, Kleinschmidt JA. Heart-targeted adeno-associated viral vectors selected by in vivo biopanning of a random viral display peptide library. Gene Ther 2010; 17:980-90; PMID:20393510; http://dx.doi.org/10.1038/gt.2010.44
  • Körbelin J, Sieber T, Michelfelder S, Lunding L, Spies E, Hunger A, Alawi M, Rapti K, Indenbirken D, Muller OJ, et al. Pulmonary Targeting of Adeno-associated Viral Vectors by Next-generation Sequencing-guided Screening of Random Capsid Displayed Peptide Libraries. Mol Ther 2016; 24(6):1050-61; PMID:27018516; http://dx.doi.org/10.1038/mt.2016.62
  • Holehonnur R, Luong JA, Chaturvedi D, Ho A, Lella SK, Hosek MP, Ploski JE. Adeno-associated viral serotypes produce differing titers and differentially transduce neurons within the rat basal and lateral amygdala. BMC Neurosci 2014; 15:28; PMID:24533621; http://dx.doi.org/10.1186/1471-2202-15-28
  • Mietzsch M, Broecker F, Reinhardt A, Seeberger PH, Heilbronn R. Differential adeno-associated virus serotype-specific interaction patterns with synthetic heparins and other glycans. J Virol 2014; 88:2991-3003; PMID:24371066; http://dx.doi.org/10.1128/JVI.03371-13
  • Pillay S, Meyer NL, Puschnik AS, Davulcu O, Diep J, Ishikawa Y, Jae LT, Wosen JE, Nagamine CM, Chapman MS, et al. An essential receptor for adeno-associated virus infection. Nature 2016; 530:108-12; PMID:26814968; http://dx.doi.org/10.1038/nature16465
  • Liaw L, Schwartz SM. Comparison of gene expression in bovine aortic endothelium in vivo versus in vitro. Differences in growth regulatory molecules. Arterioscler Thromb 1993; 13:985-93; PMID:7686396; http://dx.doi.org/10.1161/01.ATV.13.7.985
  • Staton CA, Reed MW, Brown NJ. A critical analysis of current in vitro and in vivo angiogenesis assays. Inter J Exp Pathol 2009; 90:195-221; http://dx.doi.org/10.1111/j.1365-2613.2008.00633.x